fr

CARMAT completes enrolment in the EFICAS clinical study and receives approval from French authorities for 21 additional Aeson® implants, while awaiting potential reimbursement of the device in France

press release

First-in-man implantation of CARMAT's bioprosthetic artificial heart

Download

CARMAT is participating in the EACTS Annual Meeting in Vienna (Austria)

Download

CARMAT obtains ANSM approval in France to carry out the first human implants of its artificial heart

Download

H1 2013 financial results

Download

CARMAT publishes its fourth Shareholder Newsletter

Download

CARMAT subscribes to a contingent equity line

Download

Q&A on the contingent equity line

Download

The responses to written questions to CARMAT’s Board of Directors are now available

Download
Top of page